Prior to his appointment as CSO in 2014, with the responsibility for developing the highest level of scientific excellence and enhancing Cobra’s DNA, virus, microbial and mammalian proteins research and development platforms, Daniel spent four years with the bioProcessUK team at the HealthTech & Medicines Knowledge Transfer Network (KTN), driving the innovation agenda for biologics bioprocessing in the UK as a Knowledge Transfer Manager and successfully delivering a number of projects enhancing industrial and academic collaboration.
Formerly, Daniel spent five years at Cobra in roles including Senior Scientist, QC Team Leader, Head of Process Technology Transfer and Commercial Scientific Development Manager. He has over eight years academic research experience, 20+ research publications to his name and a PhD in Molecular Cell Biology.
A statement from the the University of Warwick, School of Life Sciences:
“Dr. Smith is currently Chief Scientific Officer [...] at Cobra Biologics Ltd., but he started his scientific career here at Warwick, with a BSc in Biochemistry then a PhD on the mechanism of action at the cellular level of cytotoxic proteins such as ricin.
By becoming an honorary Industrial Professor in our School, Dr. Smith will bring widespread experience in both the workings of a multi-million budget R&D company in a sector at the forefront of biomedical products and also in academic research. His specific expertise in knowledge transfer and experience in developing successful collaborations between regional development agencies, industry and academics will be enormously useful.
Dr. Smith will bring many links with industries that we do not yet interact with, both in the UK and internationally. He will contribute ideas and contacts to help our undergraduate students secure industrial placements, a key strategic development area for the School.
Dr. Smith will also aid our technology transfer to support start-ups with commercial promise. His past work is highly interdisciplinary in both the academic and industrial sides in chemistry and biology, knowledge of which can massively impact startup success.